open access

Online first
Short communication
Published online: 2023-01-22
Get Citation

The course and treatment of COVID-19 in heart transplant recipients: A case series from the late phase of the pandemic

Alicja Nowak1, Justyna Małyszek-Tumidajewicz2, Aleksander Araszkiewicz1, Hanna Wachowiak-Baszyńska3, Magdalena Janus1, Stanisław Jankiewicz1, Sylwia Iwańczyk1, Anna Smukowska-Gorynia1, Tomasz Urbanowicz3, Marek Jemielity3, Maciej Lesiak1, Tatiana Mularek-Kubzdela1
DOI: 10.33963/KP.a2023.0024
·
Pubmed: 36682047
Affiliations
  1. 1st Department of Cardiology, Poznan University of Medical Sciences, Heliodor Swiecicki Clinical Hospital in Poznan, Poznań, Poland
  2. Department of Cardiac, Vascular and Endovascular Surgery and Transplantology in Zabrze, Medical University of Silesia in Katowice, Silesian Centre for Heart Disease, Zabrze, Poland
  3. Department of Cardiac Surgery and Transplantology, Poznan University of Medical Sciences, Heliodor Swiecicki Clinical Hospital in Poznan, Poznań, Poland

open access

Online first
Short communication
Published online: 2023-01-22

Abstract

Not available

Abstract

Not available
Get Citation
Supp./Additional Files (1)
Supplementary material
Download
153KB
About this article
Title

The course and treatment of COVID-19 in heart transplant recipients: A case series from the late phase of the pandemic

Journal

Kardiologia Polska (Polish Heart Journal)

Issue

Online first

Article type

Short communication

Published online

2023-01-22

Page views

103

Article views/downloads

29

DOI

10.33963/KP.a2023.0024

Pubmed

36682047

Authors

Alicja Nowak
Justyna Małyszek-Tumidajewicz
Aleksander Araszkiewicz
Hanna Wachowiak-Baszyńska
Magdalena Janus
Stanisław Jankiewicz
Sylwia Iwańczyk
Anna Smukowska-Gorynia
Tomasz Urbanowicz
Marek Jemielity
Maciej Lesiak
Tatiana Mularek-Kubzdela

References (11)
  1. World Health Organization. WHO coronavirus disease (SARS-COV-2) dashboard 2022. Published 2022. . Available online: https://covid19.who.int/. [Accessed: August 11, 2022].
  2. Menni C, Valdes AM, Polidori L, et al. Symptom prevalence, duration, and risk of hospital admission in individuals infected with SARS-CoV-2 during periods of omicron and delta variant dominance: a prospective observational study from the ZOE COVID Study. Lancet. 2022; 399(10335): 1618–1624.
  3. Genuardi MV, Moss N, Najjar SS, et al. Coronavirus disease 2019 in heart transplant recipients: Risk factors, immunosuppression, and outcomes. J Heart Lung Transplant. 2021; 40(9): 926–935.
  4. Bottio T, Bagozzi L, Fiocco A, et al. COVID-19 in heart transplant recipients: A multicenter analysis of the northern italian outbreak. JACC Heart Fail. 2021; 9(1): 52–61.
  5. Kuczaj A, Zakliczyński M, Przybyłowski P, et al. COVID-19 mortality in patients after orthotopic heart transplantation: A single-center one-year observational study. Kardiol Pol. 2022; 80(2): 215–217.
  6. World Health Organization. Clinical management of COVID-19: living guideline, 15 September 2022. Geneva: World Health Organization; 2022 (WHO/2019-nCoV/Clinical/2022.2). Published September 15, 2022. Available online: www.who.int/publications/i/item/WHO-2019-nCoV-Clinical-2022.2. [Accessed: September 16, 2022].
  7. Marcondes-Braga FG, Murad CM, Belfort DSP, et al. Characteristics and Outcomes of Heart Transplant Recipients With Coronavirus-19 Disease in a High-volume Transplant Center. Transplantation. 2022; 106(3): 641–647.
  8. Heldman MR, Kates OS, Safa K, et al. Changing trends in mortality among solid organ transplant recipients hospitalized for COVID-19 during the course of the pandemic. Am J Transplant. 2022; 22(1): 279–288.
  9. Flisiak R, Horban A, Jaroszewicz J, et al. Diagnosis and therapy of SARS-CoV-2 infection: recommendations of the Polish Association of Epidemiologists and Infectiologists as of November 12, 2021. Annex no. 1 to the Recommendations of April 26, 2021. Pol Arch Intern Med. 2021; 131(11).
  10. Duran JM, Lin AY, Barat M, et al. Use of Remdesivir to Treat COVID-19 after Orthotopic Heart Transplant. J Heart Lung Transplant. 2021; 40(4): S20.
  11. Shafiekhani M, Shahabinezhad F, Niknam T, et al. Evaluation of the therapeutic regimen in COVID-19 in transplant patients: where do immunomodulatory and antivirals stand? Virol J. 2021; 18(1): 228.

Regulations

Important: This website uses cookies. More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

By VM Media Group sp. z o.o., ul. Świętokrzyska 73 , 80–180 Gdańsk, Poland

phone:+48 58 320 94 94, fax:+48 58 320 94 60, e-mail: viamedica@viamedica.pl